Latest Issue

The Dubai Health Authority (DHA) has announced that an Emirati double amputee has become the first in the region to receive 3D printed transtibial prosthetics. 25-year-old Fahad Mohammed Ali, a Paralympic champion from Dubai, who had been wearing wooden prosthetic legs for over 15 years will now walk in his customised orange 3D prosthetics.

Biotechnology, tissue engineering, biomaterials and designing artificial healthy organs: Innovative new smart nano/micro encapsulated formulations can potentially function as new organs and treat diabetes. By Dr Hani Al-Salami, Senior Lecturer of Pharmaceutical Sciences and Biotechnology, Curtin Health Innovation Research Institute, Curtin University, Perth Western Australia, Australia; Laboratory Head, Biotechnology and Drug Development Research Laboratory

Informa Life Sciences Exhibitions, the world’s leading publishing and exhibitions company, has announced that the FIME Exhibition & Congress will be making a return to its original host location – the Miami Beach Convention Centre in Florida - in 2019. The show, which is the largest health expo in Americas, will be relocating back to its permanent home in Miami as the venue is expected to complete a $620-million state-of-the-art renovation project by the end of 2018.

Examining the GCC’s evolving multi-billion-dollar healthcare industry, Investcorp, a leading global provider and manager of alternative investments, has offered several recommendations in its recently launched white paper on improving the operating environment, reducing costs and increasing opportunities across the industry’s value chain.

Did you know we spend one third of our lives sleeping, or trying to sleep? So maybe we should dig a little deeper and look at how we can sleep better. “Sleep hygiene is a term used to include just about anything related to your sleep habits,” says Dr Hassan Al Hariri, Head of Sleep Medicine at Rashid Hospital. “It includes practices and habits that influence good sleep quality at night and full daytime alertness.”

Healthcare design in the Middle East and North Africa (MENA) region is going through some dynamic changes. As technology evolves, regulations change and patients become more informed, healthcare providers are having to evolve the way that these facilities are designed and managed to adapt to changing patient needs.

A report by Alpen Capital has estimated that the hospital bed density in the region averages 17 beds per 10,000 people – much lower than the 54 per 1,000 seen in high-income countries. And as the United Arab Emirates continues to grapple with this shortage of hospital beds, a number of much-needed healthcare infrastructure projects are expected to enter the market in the next few years.

Over the past few years, matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a tool for microbial identification and diagnosis. At MEDLAB 2018, Albarah El-khani, MSc (CSSBB), Director of Technical Operations at National Reference Laboratory (NRL),

According to the latest statistics released by the Health Department of Abu Dhabi, the UAE government has indicated that every year, an alarming 4,500 new cases of cancer are reported in the country. In 2016, cancer was the prominent cause of death in Abu Dhabi and Dubai at 12.8 per cent and 17.9 per cent respectively, which highlights the increasing demand for oncology services in the UAE.

A cost-effective and efficient supply chain is an integral part of a hospital or medical facility’s functioning and is one of the main tools in maximising a provider’s revenue. In fact, the cost of a hospital supply chain is only second to labour cost representing a huge burden on the efficacy of a healthcare facility.

The rising global threat of ransomware has become a grim reality. “WannaCry” virus, over a year ago, unleashed one of the worst and most widespread cybersecurity attacks ever seen that crippled business operations across the world including hospitals, government offices, telecommunications, banks and other industries critical to national infrastructure.

A demographic shift where population above the age of 60 are expected to rise considerably in the next decade, increased private sector participation and increase in health insurance coverage are amongst some of the chief factors raising the stakes for high growth opportunities in the healthcare sector landscape of the Kingdom of Saudi Arabia.

The mission statement of Cleveland Clinic, drafted nearly 100 years ago, helped to guide the work of doctors at a four-storey outpatient building in Cleveland, Ohio, when it first opened its doors to patients in 1921. Today, it remains a touchstone for more than 50,000 caregivers in an international network that includes our coordinated, multidisciplinary hospital in Abu Dhabi. The statement’s clarity and simplicity has proven to be an essential point of focus across our global footprint, even as our industry has faced a growing level of complexity and range of challenges.

By Arab Health Magazine Staff High growth opportunities abound in the healthcare market sector of the Kingdom of Saudi Arabia. The government will cumulatively spend $180 billion on healthcare over the next 5 years in both the traditional and frontier subsectors to meet demand and tackle the Kingdom’s public health challenges. As such, investors will find significant opportunities across the entire sector including hospital and healthcare services, pharmaceuticals, and medical devices.

The economics of healthcare delivery in the region is undergoing a transition owing to many factors, the most significant being the increase in the number of people with health insurance. Players who are inclined to embrace change and have an insight into what underpins the healthcare costs and revenues, stand to benefit more than their counterparts who are either resistant to change or oblivious of the intricate dynamics.

According to human data science company IQVIA, the compound annual growth rate (CAGR) for the total healthcare market in the Kingdom of Saudi Arabia (KSA) for 2018/2019 is expected to be 3%. So with the KSA market expected to continue growing in the coming years (Saudi Arabia represented 58.5% of the region’s healthcare market with current healthcare expenditure of US$ 37.7 billion in 2015)

The development of oncology treatments has grown rapidly over the last two decades. The number of active compounds in clinical development quadrupled between 1998 and 2018, and nearly doubled in the last decade alone, with more than 1,600 compounds reported today in phase I-III clinical trends data.